Project Number 5R01AG064069-03 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Antisense Oligonucleotides for Targeting Nonsense-mediated mRNA Decay in Frontotemporal Dementia Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies c. C9ORF-72 and Progranulin Researcher and Organization Principal Investigator NGUYEN, ANDREW D Principal Investigator First Name ANDREW Principal Investigator Last Name NGUYEN Awardee Organization SAINT LOUIS UNIVERSITY Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-041: DRUG DISCOVERY FOR NERVOUS SYSTEM DISORDERS (R01) FY Overall Cost $378,750 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official WISE, BRADLEY C
